<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cartilage</journal-id><journal-id journal-id-type="iso-abbrev">Cartilage</journal-id><journal-id journal-id-type="publisher-id">CAR</journal-id><journal-id journal-id-type="hwp">spcar</journal-id><journal-title-group><journal-title>Cartilage</journal-title></journal-title-group><issn pub-type="ppub">1947-6035</issn><issn pub-type="epub">1947-6043</issn><publisher><publisher-name>SAGE Publications</publisher-name><publisher-loc>Sage CA: Los Angeles, CA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26069563</article-id><article-id pub-id-type="pmc">4297057</article-id><article-id pub-id-type="doi">10.1177/1947603510376820</article-id><article-id pub-id-type="publisher-id">10.1177_1947603510376820</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Comparison between Platelet-Rich Plasma and Autologous Iliac Grafts for Tibial Osteotomy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>D&#x02019;Elia</surname><given-names>Caio Oliveira</given-names></name><xref ref-type="aff" rid="aff1-1947603510376820">1</xref><xref ref-type="corresp" rid="corresp1-1947603510376820"/></contrib><contrib contrib-type="author"><name><surname>de Rezende</surname><given-names>M&#x000e1;rcia Uch&#x000f4;a</given-names></name><xref ref-type="aff" rid="aff1-1947603510376820">1</xref></contrib><contrib contrib-type="author"><name><surname>Bitar</surname><given-names>Alexandre Carneiro</given-names></name><xref ref-type="aff" rid="aff2-1947603510376820">2</xref></contrib><contrib contrib-type="author"><name><surname>Tatsui</surname><given-names>Nelson</given-names></name><xref ref-type="aff" rid="aff1-1947603510376820">1</xref></contrib><contrib contrib-type="author"><name><surname>P&#x000e9;cora</surname><given-names>Jos&#x000e9; Ricardo</given-names></name><xref ref-type="aff" rid="aff1-1947603510376820">1</xref></contrib><contrib contrib-type="author"><name><surname>Hernandez</surname><given-names>Arnaldo Jos&#x000e9;</given-names></name><xref ref-type="aff" rid="aff1-1947603510376820">1</xref></contrib><contrib contrib-type="author"><name><surname>Camanho</surname><given-names>Gilberto Luis</given-names></name><xref ref-type="aff" rid="aff1-1947603510376820">1</xref></contrib></contrib-group><aff id="aff1-1947603510376820"><label>1</label>Hospital das Cl&#x000ed;nicas, School of Medicine of the University of S&#x000e3;o Paulo, S&#x000e3;o Paulo, Brazil</aff><aff id="aff2-1947603510376820"><label>2</label>Instituto Vita, S&#x000e3;o Paulo, Brazil</aff><author-notes><corresp id="corresp1-1947603510376820">Caio Oliveira D&#x02019;Elia, Rua Mato Grosso, 306, 1<sup>st</sup> floor, Higien&#x000f3;polis, S&#x000e3;o Paulo (SP), Brazil, Mail Box 01239-040 Email: <email>caiodelia.vita@gmail.com</email>, <email>caio@vita.org.br</email>, <email>isabela@vita.org.br</email></corresp></author-notes><pub-date pub-type="epub-ppub"><month>10</month><year>2010</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><month>10</month><year>2010</year></pub-date><volume>1</volume><issue>4</issue><fpage>320</fpage><lpage>327</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2010</copyright-statement><copyright-year>2010</copyright-year><copyright-holder content-type="sage">SAGE Publications</copyright-holder></permissions><abstract><sec id="section1-1947603510376820"><title>Objective:</title><p>Platelet-rich plasma (PRP) has the capacity to improve the bone-healing process. The aim of this pilot study was to investigate the occurrence of bone healing and the time taken to achieve this in patients submitted to medial opening wedge high tibial osteotomy (MOWHTO), comparing platelet-rich plasma with bone marrow aspirate to autologous iliac graft.</p></sec><sec id="section2-1947603510376820"><title>Design:</title><p>Twenty-five patients who underwent tibial osteotomy were randomly divided into 2 groups: a control group, which received autologous iliac grafts (14 patients), and a study group, which received a compound of PRP and bone marrow aspirate (11 patients).</p></sec><sec id="section3-1947603510376820"><title>Results:</title><p>The bone-healing rates achieved were 100% in the control group and 91% in the study group. There was no difference in the time taken to achieve bone healing between the groups.</p></sec><sec id="section4-1947603510376820"><title>Conclusions:</title><p>The use of a combination of PRP and bone marrow aspirate, as a bone substitute, did not demonstrate any advantage over the use of an autologous iliac graft in MOWHTO.</p></sec></abstract><kwd-group><kwd>platelet-rich plasma</kwd><kwd>bone marrow</kwd><kwd>bone substitutes</kwd><kwd>knee</kwd><kwd>osteotomy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="section5-1947603510376820"><title>Introduction</title><p>Autologous iliac graft is considered the gold standard among the graft materials used today and is also the most frequently used method.<sup><xref rid="bibr1-1947603510376820" ref-type="bibr">1</xref></sup> However, patients who undergo surgical procedures to harvest iliac grafts frequently present significant donor-site morbidity.<sup><xref rid="bibr2-1947603510376820" ref-type="bibr">2</xref></sup></p><p>Several studies have tried to obtain biologically compatible bone substitutes to avoid the complications associated with the harvesting procedure of autologous bone graft.<sup><xref rid="bibr1-1947603510376820" ref-type="bibr">1</xref></sup> Grafting procedures using bone marrow aspirate<sup><xref rid="bibr3-1947603510376820" ref-type="bibr">3</xref></sup> and platelet-rich plasma (PRP)<sup><xref rid="bibr4-1947603510376820" ref-type="bibr">4</xref>,<xref rid="bibr5-1947603510376820" ref-type="bibr">5</xref></sup> have been studied, with promising results. Bone marrow aspirate is an important source of osteogenic cells,<sup><xref rid="bibr6-1947603510376820" ref-type="bibr">6</xref>,<xref rid="bibr7-1947603510376820" ref-type="bibr">7</xref></sup> and PRP has the capacity to improve the bone-healing process through osteoinductive action.<sup><xref rid="bibr8-1947603510376820" ref-type="bibr">8</xref>,<xref rid="bibr9-1947603510376820" ref-type="bibr">9</xref></sup></p><p>PRP has been shown to stimulate osteoblast proliferation <italic>in vitro</italic> and to enhance bone repair, presumably because of the high levels of autologous growth factors (platelet-derived growth factor, transforming growth factor&#x02013;&#x003b2; [TGF-&#x003b2;], vascular endothelial growth factor) that do not induce immunological reactions.<sup><xref rid="bibr10-1947603510376820" ref-type="bibr">10</xref>,<xref rid="bibr11-1947603510376820" ref-type="bibr">11</xref></sup></p><p>Despite the lack of clinical studies, the use of growth factors (PRP, bone morphogenic proteins, TGF-&#x003b2;, etc.) in several orthopedic procedures has increased in the past few years. Growth factors have been used alone or in combination to treat problems affecting bone, cartilage, ligaments, and tendons.<sup><xref rid="bibr12-1947603510376820" ref-type="bibr">12</xref>-<xref rid="bibr14-1947603510376820" ref-type="bibr">14</xref></sup></p><p>The purpose of this article is to report on the initial results regarding bone healing with the use of a biological graft containing a combination of PRP and bone marrow aspirate, to be used in medial opening wedge high tibial osteotomy (MOWHTO), compared with autologous iliac bone graft (considered here as the gold standard among bone substitutes). It was hypothesized that in the evaluation of bone healing, this graft would be a satisfactory choice and would promote timely healing of the osteotomy site. This study therefore seeks to determine if PRP and bone marrow aspirate can be used as a bone substitute for autologous iliac bone graft in MOWHTO with comparable results in terms of the percentage of patients with bone healing and the time necessary to achieve this.</p></sec><sec sec-type="methods" id="section6-1947603510376820"><title>Methods</title><sec id="section7-1947603510376820"><title>Sample and Randomization Process</title><p>This study was approved by the Ethics Committee for Research on Human Beings. All patients voluntarily agreed to participate and freely signed an informed consent form.</p><p>Patients with varus deformity of the knee that was unrelated to osteometabolic diseases and who underwent MOWHTO between August 2005 and July 2007 were included in the study, regardless of the cause (unicompartmental osteoarthritis, chronic ligament deficiencies, or lower-limb deformities). The indications for tibial valgus osteotomy established in the literature were used.<sup><xref rid="bibr15-1947603510376820" ref-type="bibr">15</xref></sup> The patients required surgical correction, using wedges between 10 mm and 15 mm. Loss of follow-up was considered an exclusion factor.</p><p>The measurements of interest were 1) percentage of cases with consolidation 24 weeks after surgery and 2) time to achieve bone consolidation after the surgical procedure.</p><p>The patients were randomly distributed into 2 groups using random assignment with replacement. The control (iliac) group was composed of patients who underwent osteotomy with the use of an autologous iliac graft at the osteotomy site. The study group (PRP) was composed of patients who underwent osteotomy with the use of a bone substitute consisting of PRP and bone marrow aspirate. This bone substitute was called <italic>biological graft</italic>.</p></sec><sec id="section8-1947603510376820"><title>Surgical Technique</title><p>All surgical procedures in this study were performed by the same surgeon. The technique used to perform the osteotomy was as previously described<sup><xref rid="bibr16-1947603510376820" ref-type="bibr">16</xref></sup>: an opening wedge osteotomy, similar to the planning and surgical technique described by Puddu.<sup><xref rid="bibr17-1947603510376820" ref-type="bibr">17</xref></sup> A nonlocking, straight wedged plate was used (Arthrex).<sup><xref rid="bibr17-1947603510376820" ref-type="bibr">17</xref></sup> The iliac graft obtained was cortical cancellous, of sufficient amount to fill the gap created by the osteotomy. The iliac crest was used as the donor area, and the surgical technique was standardized.<sup><xref rid="bibr18-1947603510376820" ref-type="bibr">18</xref></sup></p><p>The platelet concentrate was obtained using an automatic cell separator (MCS Plus; Haemonetics, Braintree, MA).<sup><xref rid="bibr19-1947603510376820" ref-type="bibr">19</xref></sup> This automatic cell separator collected about 400 ml of whole blood, which resulted in 70 ml of PRP after preparation, and sodium citrate was used as an anticoagulant. The PRP platelet concentration was measured in all patients. The platelets were collected 20 minutes before surgery, immediately before anesthesia. The bone marrow aspirate was obtained from the iliac crest by percutaneous puncture, using a standardized technique with a number 14 needle guide. Six punctures were made, obtaining about 12 ml of bone marrow.<sup><xref rid="bibr20-1947603510376820" ref-type="bibr">20</xref></sup> Sodium citrate was added to this material as an anticoagulant, with a citrate:bone marrow ratio of 1:5.</p><p>The bone graft was formed by adding the bone marrow aspirate to the PRP. Autologous thrombin and 10% calcium chloride were added to this compound to form a gel. The surgeon then placed the biological graft in the surgical site (osteotomy gap).</p></sec><sec id="section9-1947603510376820"><title>Radiographic Evaluation</title><p>The method used to assess bone healing was plain radiographs, similar to what is suggested by Brinkman <italic>et al</italic>.<sup><xref rid="bibr21-1947603510376820" ref-type="bibr">21</xref></sup> The patients were evaluated every 2 weeks, to assess signs of bone healing at the osteotomy site.<sup><xref rid="bibr22-1947603510376820" ref-type="bibr">22</xref>,<xref rid="bibr23-1947603510376820" ref-type="bibr">23</xref></sup> The evaluations were carried out by 2 observers, who were blind to the type of graft that had been used in the patient, similar to the method described by Yacobucci and Cocking.<sup><xref rid="bibr23-1947603510376820" ref-type="bibr">23</xref></sup></p><p>The imaging method used was standard radiography in anteroposterior and lateral views (65 kV, 20 mA, with a focus film distance of 100 cm and an equivalent effective dose of &#x0003c;0.01 mSv within &#x000b1;2%). The indicators used to assess bone union were increasing density of the graft on serial examination and bone bridging across the wedge opening.</p><p>The time to achieve bone healing<sup><xref rid="bibr22-1947603510376820" ref-type="bibr">22</xref>,<xref rid="bibr23-1947603510376820" ref-type="bibr">23</xref></sup> was determined from this examination. The criteria used to check the occurrence of bone healing were as follows: 1) in the anteroposterior view, the presence of bone filling at least 60% of the osteotomy in the lateral-medial direction, and in the lateral view, 2) consolidation of the anterior or 3) posterior cortex. For the osteotomy to be considered united, at least 2 of these criteria had to be met (<bold><xref ref-type="fig" rid="fig1-1947603510376820">Fig. 1</xref></bold>), and the patient needed to be able to perform full weight bearing without pain or swelling at the osteotomy site.<sup><xref rid="bibr23-1947603510376820" ref-type="bibr">23</xref></sup> Signs of nonunion were absence of the above indicators at 24 weeks after surgery and sclerotic margins at the periphery of the wedge opening. If union of the osteotomy had not occurred 24 weeks after the procedure, the osteotomy was considered a nonunion (<bold><xref ref-type="fig" rid="fig2-1947603510376820">Figs. 2</xref> and <xref ref-type="fig" rid="fig3-1947603510376820">3</xref></bold>).<sup><xref rid="bibr24-1947603510376820" ref-type="bibr">24</xref></sup></p><fig id="fig1-1947603510376820" position="float"><label>Figure 1.</label><caption><p>Radiographic criteria used to access bone healing.</p></caption><graphic xlink:href="10.1177_1947603510376820-fig1"/></fig><fig id="fig2-1947603510376820" position="float"><label>Figure 2.</label><caption><p>Example of union in an osteotomy performed in a 45-year-old patient with a 12.5-mm wedge, 12 weeks to bone healing.</p></caption><graphic xlink:href="10.1177_1947603510376820-fig2"/></fig><fig id="fig3-1947603510376820" position="float"><label>Figure 3.</label><caption><p>Example of nonunion in an osteotomy performed in a 37-year-old patient with a 12.5-mm wedge, 24 weeks until considered a nonunion.</p></caption><graphic xlink:href="10.1177_1947603510376820-fig3"/></fig><p>In addition, to detect any signs of collapse at the osteotomy site, the angle of correction was measured right after the surgery and at the last follow-up, using a manual goniometer.</p></sec><sec id="section10-1947603510376820"><title>Statistical Analysis and Power</title><p>The occurrence of union was compared between the groups, by means of the Fisher exact test. The target difference was 10% between the groups.</p><p>The consolidation time (survival time) was defined as the period, in weeks, between the date of surgery and the date of consolidation, and it was evaluated by the construction of Kaplan-Meier curves. The curves for the 2 groups were compared, using the log-rank and Breslow statistical tests.</p></sec></sec><sec sec-type="results" id="section11-1947603510376820"><title>Results</title><p>During the study period, surgery was performed in 25 patients; 14 were allocated to the control group, and 11 to the study group. There was no loss of follow-up. The results of this series are described below.</p><p>Regarding the angle of correction, the mean angle of correction (initial measure) was 10.8&#x000b0; in the control group and 11.1&#x000b0; in the study group. The mean angle of correction (final measure) was 10.6&#x000b0; in the control group and 11.0&#x000b0; in the study group. Evaluating the patients separately, there was also no loss of correction.</p><p>The most frequent indication for surgery, in both groups, was chronic injury of the anterior cruciate ligament. The diagnoses were evaluated once and grouped into 3 categories (<bold><xref ref-type="table" rid="table1-1947603510376820">Table 1</xref></bold>). The analysis did not indicate any association between these categories and the study groups (<italic>P</italic> = 0.168). The patient sample was also homogenous in terms of the patient&#x02019;s gender and smoking habits (<bold><xref ref-type="table" rid="table1-1947603510376820">Table 1</xref></bold>).</p><table-wrap id="table1-1947603510376820" position="float"><label>Table 1.</label><caption><p>Distribution of the Patients in the Autologous Iliac Graft and Platelet-Rich Plasma Groups According to Sex, Tobacco Use, and Diagnosis</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Group</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Iliac</th><th align="center" rowspan="1" colspan="1">PRP</th><th align="center" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Diagnosis (<italic>P</italic> = 0.168)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Chronic ACL lesion<sup><xref ref-type="table-fn" rid="table-fn2-1947603510376820">a</xref></sup></td><td rowspan="1" colspan="1">6 (42.9%)</td><td rowspan="1" colspan="1">9 (81.2%)</td><td rowspan="1" colspan="1">15 (60.0%)</td></tr><tr><td rowspan="1" colspan="1">Medial arthritis<sup><xref ref-type="table-fn" rid="table-fn3-1947603510376820">b</xref></sup></td><td rowspan="1" colspan="1">5 (35.7%)</td><td rowspan="1" colspan="1">1 (9.1%)</td><td rowspan="1" colspan="1">6 (24.0%)</td></tr><tr><td rowspan="1" colspan="1">Deformities<sup><xref ref-type="table-fn" rid="table-fn4-1947603510376820">c</xref></sup></td><td rowspan="1" colspan="1">3 (21.4%)</td><td rowspan="1" colspan="1">1 (9.1%)</td><td rowspan="1" colspan="1">4 (16.0%)</td></tr><tr><td rowspan="1" colspan="1">Gender (<italic>P</italic> = 0.183)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">2 (14.3%)</td><td rowspan="1" colspan="1">2 (18.2%)</td><td rowspan="1" colspan="1">4 (16.0%)</td></tr><tr><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">12 (85.7%)</td><td rowspan="1" colspan="1">9 (81.8%)</td><td rowspan="1" colspan="1">21 (84.0%)</td></tr><tr><td rowspan="1" colspan="1">Smoker (<italic>P</italic> &#x0003e; 0.99)</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">14 (100%)</td><td rowspan="1" colspan="1">9 (81.8%)</td><td rowspan="1" colspan="1">23 (92.0%)</td></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">2</td><td rowspan="1" colspan="1">2</td></tr><tr><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">14 (100%)</td><td rowspan="1" colspan="1">11 (100%)</td><td rowspan="1" colspan="1">25 (100%)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn1-1947603510376820"><p>Note: <italic>P</italic> values related to Fisher&#x02019;s exact test. ACL = anterior cruciate ligament.</p></fn><fn id="table-fn2-1947603510376820"><label>a.</label><p>Double varus or triple varus.</p></fn><fn id="table-fn3-1947603510376820"><label>b.</label><p>Also includes osteonecrosis.</p></fn><fn id="table-fn4-1947603510376820"><label>c.</label><p>Genu varus or sequelae of fractures.</p></fn></table-wrap-foot></table-wrap><p>The mean age of the patients was 42.4 years (&#x000b1;8.5). For the iliac group, the mean age was 45.9 years (&#x000b1;8.1), and for the PRP group, 37.8 years (&#x000b1;6.9). The mean age was significantly higher in the iliac group, with <italic>P</italic> = 0.014 (Student&#x02019;s <italic>t</italic>-test). In view of the difference in mean age found between the 2 groups, a dispersion graph was constructed to correlate the consolidation time with the patients&#x02019; ages, as shown in <bold><xref ref-type="fig" rid="fig4-1947603510376820">Figure 4</xref></bold>. In general, <bold><xref ref-type="fig" rid="fig4-1947603510376820">Figure 4</xref></bold> indicates a low correlation between age and consolidation time, for both cases taken together (<italic>n</italic> = 25) and for each group separately.</p><fig id="fig4-1947603510376820" position="float"><label>Figure 4.</label><caption><p>Dispersion graph showing time for bone healing versus patient age.</p></caption><graphic xlink:href="10.1177_1947603510376820-fig4"/></fig><sec id="section12-1947603510376820"><title>Consolidation</title><sec id="section13-1947603510376820"><title>1. Can PRP be used as a substitute for autologous iliac bone graft, with comparable results regarding the percentage of patients who achieve bone healing?</title><p>The percentages of consolidation, 24 weeks after surgery, were the same for both groups in this initial series of 25 patients: The consolidation rate reached 100% in the iliac group and 91% in the PRP group, with <italic>P</italic> = 0.440. <bold><xref ref-type="table" rid="table2-1947603510376820">Table 2</xref></bold> shows the distribution of patients in the iliac and PRP groups, according to their consolidation 24 weeks after surgery.</p><table-wrap id="table2-1947603510376820" position="float"><label>Table 2.</label><caption><p>Distribution of the Patients in the Autologous Iliac Graft and Platelet-Rich Plasma Groups, According to Consolidation after 24 Weeks (<italic>P</italic> = 0.440; Fisher&#x02019;s Exact Test)</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Group</th><th rowspan="1" colspan="1"/></tr><tr><th align="left" rowspan="1" colspan="1">Consolidation after 24 Weeks</th><th align="center" rowspan="1" colspan="1">Iliac</th><th align="center" rowspan="1" colspan="1">PRP</th><th align="center" rowspan="1" colspan="1">Total</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">14 (100%)</td><td rowspan="1" colspan="1">10 (90.9%)</td><td rowspan="1" colspan="1">24 (96.0%)</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">0</td><td rowspan="1" colspan="1">1 (9.1%)</td><td rowspan="1" colspan="1">1 (4.0%)</td></tr><tr><td rowspan="1" colspan="1">Total</td><td rowspan="1" colspan="1">14 (100%)</td><td rowspan="1" colspan="1">11 (100%)</td><td rowspan="1" colspan="1">25 (100%)</td></tr></tbody></table></table-wrap></sec><sec id="section14-1947603510376820"><title>2. Can PRP be used as a substitute for autologous iliac bone graft, with comparable results regarding the time necessary to achieve bone healing?</title><p>The consolidation time can be analyzed in <bold><xref ref-type="fig" rid="fig5-1947603510376820">Figure 5</xref></bold>, which illustrates the Kaplan-Meier survival curves obtained for each group, up to 24 weeks after surgery. The estimated values and the respective 95% confidence intervals for these data are shown in <bold><xref ref-type="table" rid="table3-1947603510376820">Table 3</xref></bold>. It can be seen that from the 8th week onward, the consolidation time is longer for the patients in the PRP group. Moreover, for this group, about 36% of the patients had still not presented consolidation 16 weeks after the surgery, while in the iliac group, this percentage dropped to 7%. It was also observed that after 24 weeks, the estimated likelihood of consolidation was 100% for the iliac group and 90.9% for the PRP.</p><fig id="fig5-1947603510376820" position="float"><label>Figure 5.</label><caption><p>Kaplan-Meier estimates for the autologous iliac and platelet-rich plasma (PRP) groups. The + represents the occurrence of a censure.</p></caption><graphic xlink:href="10.1177_1947603510376820-fig5"/></fig><table-wrap id="table3-1947603510376820" position="float"><label>Table 3.</label><caption><p>Kaplan-Meier Estimates and 95% Confidence Intervals for the Time Taken for Consolidation (Weeks) in Autologous Iliac Graft and Platelet-Rich Plasma Groups</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="center" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Time</th><th align="center" rowspan="1" colspan="1">Estimate (%)</th><th align="center" rowspan="1" colspan="1">Standard Error (%)</th><th align="center" rowspan="1" colspan="1">95% CI</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Iliac</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">78.6</td><td rowspan="1" colspan="1">11.0</td><td rowspan="1" colspan="1">47.2-92.5</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">57.1</td><td rowspan="1" colspan="1">13.2</td><td rowspan="1" colspan="1">28.4-78.0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">35.7</td><td rowspan="1" colspan="1">12.8</td><td rowspan="1" colspan="1">13.0-59.4</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">21.4</td><td rowspan="1" colspan="1">11.0</td><td rowspan="1" colspan="1">5.2-44.8</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">7.1</td><td rowspan="1" colspan="1">6.9</td><td rowspan="1" colspan="1">0.5-27.5</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">24</td><td rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">&#x02014;</td><td rowspan="1" colspan="1">&#x02014;</td></tr><tr><td rowspan="1" colspan="1">PRP</td><td rowspan="1" colspan="1">8</td><td rowspan="1" colspan="1">90.9</td><td rowspan="1" colspan="1">8.7</td><td rowspan="1" colspan="1">50.8-98.7</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">81.8</td><td rowspan="1" colspan="1">11.6</td><td rowspan="1" colspan="1">44.7-95.1</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">12</td><td rowspan="1" colspan="1">63.6</td><td rowspan="1" colspan="1">14.5</td><td rowspan="1" colspan="1">29.7-84.5</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">54.5</td><td rowspan="1" colspan="1">15.0</td><td rowspan="1" colspan="1">22.9-78.0</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">15</td><td rowspan="1" colspan="1">45.5</td><td rowspan="1" colspan="1">15.0</td><td rowspan="1" colspan="1">16.7-70.7</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">16</td><td rowspan="1" colspan="1">36.4</td><td rowspan="1" colspan="1">14.5</td><td rowspan="1" colspan="1">11.2-62.7</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">18</td><td rowspan="1" colspan="1">27.3</td><td rowspan="1" colspan="1">13.4</td><td rowspan="1" colspan="1">6.5-53.9</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">20</td><td rowspan="1" colspan="1">18.2</td><td rowspan="1" colspan="1">11.6</td><td rowspan="1" colspan="1">2.9-44.2</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">22</td><td rowspan="1" colspan="1">9.1</td><td rowspan="1" colspan="1">8.7</td><td rowspan="1" colspan="1">0.5-33.3</td></tr></tbody></table></table-wrap><p>The median consolidation time (i.e., the time taken for about 50% of the patients to present consolidation) can also be observed in <bold><xref ref-type="fig" rid="fig5-1947603510376820">Figure 5</xref></bold>. The estimated median time was 15 weeks for the PRP group and 12 weeks for the iliac group. The median time can also be obtained by linear interpolation from the results presented in <bold><xref ref-type="table" rid="table3-1947603510376820">Table 3</xref></bold>. Thus, the median consolidation time was 14.5 weeks for the PRP group, whereas for the patients in the iliac group, this time was shorter (10.7 weeks; <bold><xref ref-type="table" rid="table4-1947603510376820">Table 4</xref></bold>).</p><table-wrap id="table4-1947603510376820" position="float"><label>Table 4.</label><caption><p>Descriptive Measurements for the Time Taken to Achieve Consolidation (Weeks) for the Autologous Iliac Graft vs. PRP Groups</p></caption><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Group</th><th align="center" rowspan="1" colspan="1">Median (Weeks)</th><th align="center" rowspan="1" colspan="1">95% CI</th><th align="center" rowspan="1" colspan="1">Patients</th><th align="center" rowspan="1" colspan="1">Consolidation</th><th align="center" rowspan="1" colspan="1">Censored</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Iliac</td><td rowspan="1" colspan="1">10.7</td><td rowspan="1" colspan="1">7.2-13.0</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">14</td><td rowspan="1" colspan="1">0 (0.0%)</td></tr><tr><td rowspan="1" colspan="1">PRP</td><td rowspan="1" colspan="1">14.5</td><td rowspan="1" colspan="1">9.6-17.8</td><td rowspan="1" colspan="1">11</td><td rowspan="1" colspan="1">10</td><td rowspan="1" colspan="1">1 (9.1%)</td></tr></tbody></table><table-wrap-foot><fn id="table-fn5-1947603510376820"><p>Note: Median values obtained by linear interpolation.</p></fn></table-wrap-foot></table-wrap><p>No strong evidence was found of any difference in the survival curves, comparing the iliac and the PRP groups; that is, there was no statistical difference in consolidation time between the groups, either by the log-rank test (<italic>P</italic> = 0.129) or by the Breslow test (<italic>P</italic> = 0.100).</p></sec></sec></sec><sec sec-type="discussion" id="section15-1947603510376820"><title>Discussion</title><p>Orthopedic surgeons need to develop techniques and materials that will enable bone substitution.<sup><xref rid="bibr1-1947603510376820" ref-type="bibr">1</xref></sup> It was hypothesized that the use of a combination of PRP and bone marrow aspirate as a bone substitute would be effective in obtaining bone healing in MOWHTO, within an adequate time, and without the morbidity associated with autologous iliac harvesting.<sup><xref rid="bibr18-1947603510376820" ref-type="bibr">18</xref></sup></p><p>There are no reports in the literature on the clinical use of PRP together with bone marrow aspirate as a bone substitute comparing its results with that of autologous iliac graft in MOWHTO.</p><p>The need of bone graft or bone substitute when performing MOWHTO is still debated. No prospective randomized trials have yet been published that compare the various filling materials with no filling at all.<sup><xref rid="bibr21-1947603510376820" ref-type="bibr">21</xref></sup></p><p>Bone marrow contains hematopoietic and nonhematopoietic stromal cells, from which osteoclasts and osteoblasts, respectively, originate. The inducible osteogenic precursor cells are capable of forming osteogenic tissue in the presence of inducers or stimulatory factors such as the ones released from platelet-derived growth factors.<sup><xref rid="bibr7-1947603510376820" ref-type="bibr">7</xref></sup></p><p>Like other authors,<sup><xref rid="bibr24-1947603510376820" ref-type="bibr">24</xref></sup> we chose not to evaluate the clinical outcome of MOWHTO because this is already well documented in the literature<sup><xref rid="bibr16-1947603510376820" ref-type="bibr">16</xref>,<xref rid="bibr25-1947603510376820" ref-type="bibr">25</xref></sup> and should not be affected by the choice of graft, provided the osteotomy unites and the wedge construct does not collapse. No signs of collapse were observed at the osteotomies because the initial and final measurements of the angle of correction were similar in all patients.</p><p>As shown by other studies in this field,<sup><xref rid="bibr22-1947603510376820" ref-type="bibr">22</xref>-<xref rid="bibr27-1947603510376820" ref-type="bibr">27</xref></sup> there are some limitations in performing a study on MOWHTO, regarding the number of patients needed to achieve statistical power for the analysis of the results. The sample size needed to achieve statistical difference would be extremely high, and the frequency of the conditions that indicate the procedure are relatively low.<sup><xref rid="bibr21-1947603510376820" ref-type="bibr">21</xref>,<xref rid="bibr23-1947603510376820" ref-type="bibr">23</xref>,<xref rid="bibr28-1947603510376820" ref-type="bibr">28</xref></sup> Therefore, a multicenter study would be needed to reach the ideal sample size. A retrospective power analysis and an analysis of variance test were performed, and our study was found to be underpowered.<sup><xref rid="bibr22-1947603510376820" ref-type="bibr">22</xref>-<xref rid="bibr25-1947603510376820" ref-type="bibr">25</xref></sup></p><p>There is a lack of clinical studies, especially prospective and randomized studies, comparing the use of bone substitutes with the technique that is still considered the standard for grafting (i.e., autologous iliac bone graft).<sup><xref rid="bibr1-1947603510376820" ref-type="bibr">1</xref>,<xref rid="bibr2-1947603510376820" ref-type="bibr">2</xref>,<xref rid="bibr22-1947603510376820" ref-type="bibr">22</xref></sup> The study presents this design with an evaluation and comparison of the performance of 2 types of grafts (iliac vs. biological) regarding bone healing in a standardized procedure: MOWHTO.</p><p>PRP has significant osteoinductive action, as demonstrated by various experimental studies.<sup><xref rid="bibr9-1947603510376820" ref-type="bibr">9</xref>,<xref rid="bibr19-1947603510376820" ref-type="bibr">19</xref>,<xref rid="bibr29-1947603510376820" ref-type="bibr">29</xref></sup> It has widespread clinical application in the field of oral and maxillofacial surgery and is used as a bone promotion agent in a variety of situations.<sup><xref rid="bibr10-1947603510376820" ref-type="bibr">10</xref></sup> Its clinical use in orthopedics has been increasing, despite the absence of prospective and randomized studies evaluating the results of its use.<sup><xref rid="bibr30-1947603510376820" ref-type="bibr">30</xref>,<xref rid="bibr31-1947603510376820" ref-type="bibr">31</xref></sup></p><p>The obtainment method of PRP is of major importance because different methods have different capacity to concentrate platelets<sup><xref rid="bibr32-1947603510376820" ref-type="bibr">32</xref>,<xref rid="bibr33-1947603510376820" ref-type="bibr">33</xref></sup> and there is a direct correlation between the number of platelets in the PRP and the growth factor concentration. Marx <italic>et al</italic>.<sup><xref rid="bibr8-1947603510376820" ref-type="bibr">8</xref>,<xref rid="bibr34-1947603510376820" ref-type="bibr">34</xref></sup> and Kawasumi <italic>et al</italic>.<sup><xref rid="bibr35-1947603510376820" ref-type="bibr">35</xref></sup> suggested that the ideal concentration of platelets to be used as an enhancement factor in procedures involving bone and soft tissue should be about 1,000,000 platelets/&#x000b5;l. Most commercially available devices are merely modifications of laboratory centrifuges and do not have the capacity to adequately produce PRP. In the present study, an automatic cell separator was used (Haemonetics MCS Plus),<sup><xref rid="bibr19-1947603510376820" ref-type="bibr">19</xref>,<xref rid="bibr36-1947603510376820" ref-type="bibr">36</xref></sup> and it produces PRP with an ideal concentration of platelets.</p><p>Mesenchymal stem cells are present in bone marrow aspirates, and when associated with substances with osteoinductive or osteoconductive properties, they have already proven to be an alternative to autologous grafts.<sup><xref rid="bibr7-1947603510376820" ref-type="bibr">7</xref>,<xref rid="bibr37-1947603510376820" ref-type="bibr">37</xref></sup> In a study on canines, Yamada <italic>et al</italic>.<sup><xref rid="bibr37-1947603510376820" ref-type="bibr">37</xref></sup> demonstrated that PRP has osteogenic capacity when used in association with mesenchymal stem cells. This osteogenic capacity was found in our study, as seen with the occurrence of consolidation of the osteotomy site, but it was not significantly different between the groups (<italic>P</italic> = 0.440).</p><p>In their work, Dallari <italic>et al</italic>.<sup><xref rid="bibr22-1947603510376820" ref-type="bibr">22</xref></sup> demonstrated that PRP in association with mesenchymal stem cells derived from bone marrow aspirate is capable of producing consolidation at the osteotomy site in MOWHTO. However, they did not include a control group composed of patients who had received only autologous bone grafts.</p><p>Despite the excellent clinical results obtained from osteotomy with the addition of a medial wedge,<sup><xref rid="bibr21-1947603510376820" ref-type="bibr">21</xref>,<xref rid="bibr25-1947603510376820" ref-type="bibr">25</xref></sup> one of the main drawbacks of this procedure is the length of time during which the patient must remain in a non- or partial-weight-bearing regimen until local bone healing is achieved. Any bone substitute that is to be used in this type of procedure must be compared with autologous graft, in terms of the occurrence of consolidation as well as the time required to achieve this, as in the present study. The biological graft consisting of PRP and bone marrow did not demonstrate any advantage over autologous iliac grafts (<bold><xref ref-type="fig" rid="fig6-1947603510376820">Fig. 6</xref></bold>) in terms of achieving consolidation at the osteotomy site (<italic>P</italic> = 0.440).</p><fig id="fig6-1947603510376820" position="float"><label>Figure 6.</label><caption><p>Radiographs after bone healing of patients with anterior cruciate ligament chronic injuries submitted to tibial opening wedge osteotomy: the 1st patient (<bold>A</bold>) is a 53-year-old male with a 15-mm wedge evaluated 14 weeks after receiving autologous iliac graft. The 2nd patient (<bold>B</bold>) is a 34-year-old woman with a 12.5-mm wedge evaluated 8 weeks after receiving a compound of platelet-rich plasma and bone marrow aspirate.</p></caption><graphic xlink:href="10.1177_1947603510376820-fig6"/></fig><p>Regarding bone healing time, the PRP group required a longer period in this study. This may be considered a great disadvantage, in view of the longer time that the patient must remain with load-bearing restrictions. However, the differences were not statistically significant (<italic>P</italic> &#x0003e; 0.1). But the low power of the test presented here points out that the results should be seen only as indicative.</p><p>The use of a combination of PRP and bone marrow aspirate, as a bone substitute, did not demonstrate any advantage over the use of an autologous iliac graft in MOWHTO.</p></sec></body><back><fn-group><fn fn-type="conflict"><p><bold>Declaration of Conflicting Interests:</bold> The authors declared no potential conflicts of interest with respect to the authorship and/or publication of this article.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding:</bold> The authors received no financial support for the research and/or authorship of this article. Ethical review board statement: This study was approved by the Ethics Committee of Hospital das Cl&#x000ed;nicas, School of Medicine of the University of S&#x000e3;o Paulo.</p></fn></fn-group><ref-list><title>References</title><ref id="bibr1-1947603510376820"><label>1.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Long</surname><given-names>WG</given-names><suffix>Jr</suffix></name><name><surname>Einhorn</surname><given-names>TA</given-names></name><name><surname>Koval</surname><given-names>K</given-names></name><name><surname>McKee</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>W</given-names></name><name><surname>Sanders</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Bone grafts and bone graft substitutes in orthopaedic trauma surgery: a critical analysis</article-title>. <source>J Bone Joint Surg Am</source>. <year>2007</year>;<volume>89</volume>:<fpage>649</fpage>-<lpage>58</lpage>.<pub-id pub-id-type="pmid">17332116</pub-id></mixed-citation></ref><ref id="bibr2-1947603510376820"><label>2.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sen</surname><given-names>MK</given-names></name><name><surname>Miclau</surname><given-names>T</given-names></name></person-group>
<article-title>Autologous iliac crest bone graft: should it still be the gold standard for treating nonunions?</article-title>
<source>Injury</source>. <year>2007</year>;<volume>38</volume>(<issue>suppl 1</issue>):<fpage>S75</fpage>-<lpage>80</lpage>.<pub-id pub-id-type="pmid">17383488</pub-id></mixed-citation></ref><ref id="bibr3-1947603510376820"><label>3.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>JF</given-names></name></person-group>
<article-title>Injectable bone marrow preparations to stimulate osteogenic repair</article-title>. <source>Clin Orthop Relat Res</source>. <year>1995</year>;(<issue>313</issue>):<fpage>8</fpage>-<lpage>18</lpage>.<pub-id pub-id-type="pmid">7641502</pub-id></mixed-citation></ref><ref id="bibr4-1947603510376820"><label>4.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ito</surname><given-names>K</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Nagasaka</surname><given-names>T</given-names></name><name><surname>Baba</surname><given-names>S</given-names></name><name><surname>Ueda</surname><given-names>M</given-names></name></person-group>
<article-title>Osteogenic potential of injectable tissue-engineered bone: a comparison among autogenous bone, bone substitute (Bio-oss), platelet-rich plasma, and tissue-engineered bone with respect to their mechanical properties and histological findings</article-title>. <source>J Biomed Mater Res A</source>. <year>2005</year>;<volume>73</volume>:<fpage>63</fpage>-<lpage>72</lpage>.<pub-id pub-id-type="pmid">15714500</pub-id></mixed-citation></ref><ref id="bibr5-1947603510376820"><label>5.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dallari</surname><given-names>D</given-names></name><name><surname>Fini</surname><given-names>M</given-names></name><name><surname>Stagni</surname><given-names>C</given-names></name><name><surname>Torricelli</surname><given-names>P</given-names></name><name><surname>Nicoli Aldini</surname><given-names>N</given-names></name><etal/></person-group>
<article-title><italic>In vivo</italic> study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination</article-title>. <source>J Orthop Res</source>. <year>2006</year>;<volume>24</volume>:<fpage>877</fpage>-<lpage>88</lpage>.<pub-id pub-id-type="pmid">16609976</pub-id></mixed-citation></ref><ref id="bibr6-1947603510376820"><label>6.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>JF</given-names></name><name><surname>Guse</surname><given-names>R</given-names></name><name><surname>Tiedeman</surname><given-names>J</given-names></name><name><surname>Dehne</surname><given-names>R</given-names></name></person-group>
<article-title>Autologous marrow injection for delayed unions of the tibia: a preliminary report</article-title>. <source>J Orthop Trauma</source>. <year>1989</year>;<volume>3</volume>:<fpage>276</fpage>-<lpage>82</lpage>.<pub-id pub-id-type="pmid">2600692</pub-id></mixed-citation></ref><ref id="bibr7-1947603510376820"><label>7.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Connolly</surname><given-names>JF</given-names></name></person-group>
<article-title>Clinical use of marrow osteoprogenitor cells to stimulate osteogenesis</article-title>. <source>Clin Orthop Relat Res</source>. <year>1998</year>;(<issue>355 suppl</issue>):<fpage>S257</fpage>-<lpage>66</lpage>.<pub-id pub-id-type="pmid">9917645</pub-id></mixed-citation></ref><ref id="bibr8-1947603510376820"><label>8.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marx</surname><given-names>RE</given-names></name></person-group>
<article-title>Platelet-rich plasma: evidence to support its use</article-title>. <source>J Oral Maxillofac Surg</source>. <year>2004</year>;<volume>62</volume>:<fpage>489</fpage>-<lpage>96</lpage>.<pub-id pub-id-type="pmid">15085519</pub-id></mixed-citation></ref><ref id="bibr9-1947603510376820"><label>9.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lucarelli</surname><given-names>E</given-names></name><name><surname>Fini</surname><given-names>M</given-names></name><name><surname>Beccheroni</surname><given-names>A</given-names></name><name><surname>Giavaresi</surname><given-names>G</given-names></name><name><surname>Di Bella</surname><given-names>C</given-names></name><name><surname>Aldini</surname><given-names>NN</given-names></name><etal/></person-group>
<article-title>Stromal stem cells and platelet-rich plasma improve bone allograft integration</article-title>. <source>Clin Orthop Relat Res</source>. <year>2005</year>;(<issue>435</issue>):<fpage>62</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">15930922</pub-id></mixed-citation></ref><ref id="bibr10-1947603510376820"><label>10.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marx</surname><given-names>RE</given-names></name></person-group>
<article-title>Platelet-rich plasma (PRP): what is PRP and what is not PRP?</article-title>
<source>Implant Dent</source>. <year>2001</year>;<volume>10</volume>:<fpage>225</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">11813662</pub-id></mixed-citation></ref><ref id="bibr11-1947603510376820"><label>11.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Andrew</surname><given-names>JG</given-names></name><name><surname>Hoyland</surname><given-names>JA</given-names></name><name><surname>Freemont</surname><given-names>AJ</given-names></name><name><surname>Marsh</surname><given-names>DR</given-names></name></person-group>
<article-title>Platelet-derived growth factor expression in normally healing human fractures</article-title>. <source>Bone</source>. <year>1995</year>;<volume>16</volume>:<fpage>455</fpage>-<lpage>60</lpage>.<pub-id pub-id-type="pmid">7605706</pub-id></mixed-citation></ref><ref id="bibr12-1947603510376820"><label>12.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kovacevic</surname><given-names>D</given-names></name><name><surname>Rodeo</surname><given-names>SA</given-names></name></person-group>
<article-title>Biological augmentation of rotator cuff tendon repair</article-title>. <source>Clin Orthop Relat Res</source>. <year>2008</year>;<volume>466</volume>:<fpage>622</fpage>-<lpage>33</lpage>.<pub-id pub-id-type="pmid">18264850</pub-id></mixed-citation></ref><ref id="bibr13-1947603510376820"><label>13.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>A</given-names></name><name><surname>Doumas</surname><given-names>C</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>JP</given-names></name><name><surname>Parsons</surname><given-names>JR</given-names></name><name><surname>Lin</surname><given-names>SS</given-names></name></person-group>
<article-title>The effects of local platelet rich plasma delivery on diabetic fracture healing</article-title>. <source>Bone</source>. <year>2006</year>;<volume>38</volume>:<fpage>540</fpage>-<lpage>6</lpage>.<pub-id pub-id-type="pmid">16368279</pub-id></mixed-citation></ref><ref id="bibr14-1947603510376820"><label>14.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>M</given-names></name><name><surname>Anitua</surname><given-names>E</given-names></name><name><surname>Azofra</surname><given-names>J</given-names></name><name><surname>Andia</surname><given-names>I</given-names></name><name><surname>Padilla</surname><given-names>S</given-names></name><name><surname>Mujika</surname><given-names>I</given-names></name></person-group>
<article-title>Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices</article-title>. <source>Am J Sports Med</source>. <year>2007</year>;<volume>35</volume>:<fpage>245</fpage>-<lpage>51</lpage>.<pub-id pub-id-type="pmid">17099241</pub-id></mixed-citation></ref><ref id="bibr15-1947603510376820"><label>15.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noyes</surname><given-names>FR</given-names></name><name><surname>Barber-Westin</surname><given-names>SD</given-names></name><name><surname>Hewett</surname><given-names>TE</given-names></name></person-group>
<article-title>High tibial osteotomy and ligament reconstruction for varus angulated anterior cruciate ligament-deficient knees</article-title>. <source>Am J Sports Med</source>. <year>2000</year>;<volume>28</volume>:<fpage>282</fpage>-<lpage>96</lpage>.<pub-id pub-id-type="pmid">10843117</pub-id></mixed-citation></ref><ref id="bibr16-1947603510376820"><label>16.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amendola</surname><given-names>A</given-names></name><name><surname>Panarella</surname><given-names>L</given-names></name></person-group>
<article-title>High tibial osteotomy for the treatment of unicompartmental arthritis of the knee</article-title>. <source>Orthop Clin North Am</source>. <year>2005</year>;<volume>36</volume>:<fpage>497</fpage>-<lpage>504</lpage>.<pub-id pub-id-type="pmid">16164954</pub-id></mixed-citation></ref><ref id="bibr17-1947603510376820"><label>17.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Franco</surname><given-names>V</given-names></name><name><surname>Cerullo</surname><given-names>G</given-names></name><name><surname>Cipolla</surname><given-names>M</given-names></name><name><surname>Gianni</surname><given-names>E</given-names></name><name><surname>Puddu</surname><given-names>G</given-names></name></person-group>
<article-title>Open wedge high tibial osteotomy</article-title>. <source>Tech Knee Surg</source>. <year>2002</year>;<volume>1</volume>:<fpage>43</fpage>-<lpage>53</lpage>.</mixed-citation></ref><ref id="bibr18-1947603510376820"><label>18.</label><mixed-citation publication-type="book">
<person-group person-group-type="author"><name><surname>Crenshaw</surname><given-names>AH</given-names></name></person-group>
<article-title>Surgical techniques and approaches</article-title>. In: <person-group person-group-type="editor"><name><surname>Canale</surname><given-names>ST</given-names></name></person-group>, editor. <source>Campbell&#x02019;s operative orthopaedics</source>. <publisher-loc>Philadelphia</publisher-loc>: <publisher-name>Mosby</publisher-name>; <year>2003</year> p. <fpage>14</fpage>-<lpage>7</lpage>.</mixed-citation></ref><ref id="bibr19-1947603510376820"><label>19.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Floryan</surname><given-names>KM</given-names></name><name><surname>Berghoff</surname><given-names>WJ</given-names></name></person-group>
<article-title>Intraoperative use of autologous platelet-rich and platelet-poor plasma for orthopedic surgery patients</article-title>. <source>AORN J</source>. <year>2004</year>;<volume>80</volume>:<fpage>668</fpage>-<lpage>74</lpage>.<pub-id pub-id-type="pmid">15526700</pub-id></mixed-citation></ref><ref id="bibr20-1947603510376820"><label>20.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muschler</surname><given-names>GF</given-names></name><name><surname>Boehm</surname><given-names>C</given-names></name><name><surname>Easley</surname><given-names>K</given-names></name></person-group>
<article-title>Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume</article-title>. <source>J Bone Joint Surg Am</source>. <year>1997</year>;<volume>79</volume>:<fpage>1699</fpage>-<lpage>709</lpage>.<pub-id pub-id-type="pmid">9384430</pub-id></mixed-citation></ref><ref id="bibr21-1947603510376820"><label>21.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Brinkman</surname><given-names>JM</given-names></name><name><surname>Lobenhoffer</surname><given-names>P</given-names></name><name><surname>Agneskirchner</surname><given-names>JD</given-names></name><name><surname>Staubli</surname><given-names>AE</given-names></name><name><surname>Wymenga</surname><given-names>AB</given-names></name><name><surname>van Heerwaarden</surname><given-names>RJ</given-names></name></person-group>
<article-title>Osteotomies around the knee: patient selection, stability of fixation and bone healing in high tibial osteotomies</article-title>. <source>J Bone Joint Surg Br</source>. <year>2008</year>;<volume>90</volume>:<fpage>1548</fpage>-<lpage>57</lpage>.<pub-id pub-id-type="pmid">19043123</pub-id></mixed-citation></ref><ref id="bibr22-1947603510376820"><label>22.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dallari</surname><given-names>D</given-names></name><name><surname>Savarino</surname><given-names>L</given-names></name><name><surname>Stagni</surname><given-names>C</given-names></name><name><surname>Cenni</surname><given-names>E</given-names></name><name><surname>Cenacchi</surname><given-names>A</given-names></name><name><surname>Fornasari</surname><given-names>PM</given-names></name><etal/></person-group>
<article-title>Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells</article-title>. <source>J Bone Joint Surg Am</source>. <year>2007</year>;<volume>89</volume>:<fpage>2413</fpage>-<lpage>20</lpage>.<pub-id pub-id-type="pmid">17974883</pub-id></mixed-citation></ref><ref id="bibr23-1947603510376820"><label>23.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yacobucci</surname><given-names>GN</given-names></name><name><surname>Cocking</surname><given-names>MR</given-names></name></person-group>
<article-title>Union of medial opening-wedge high tibial osteotomy using a corticocancellous proximal tibial wedge allograft</article-title>. <source>Am J Sports Med</source>. <year>2008</year>;<volume>36</volume>:<fpage>713</fpage>-<lpage>9</lpage>.<pub-id pub-id-type="pmid">18227231</pub-id></mixed-citation></ref><ref id="bibr24-1947603510376820"><label>24.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Warden</surname><given-names>SJ</given-names></name><name><surname>Morris</surname><given-names>HG</given-names></name><name><surname>Crossley</surname><given-names>KM</given-names></name><name><surname>Brukner</surname><given-names>PD</given-names></name><name><surname>Bennell</surname><given-names>KL</given-names></name></person-group>
<article-title>Delayed- and non-union following opening wedge high tibial osteotomy: surgeons&#x02019; results from 182 completed cases</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2005</year>;<volume>13</volume>:<fpage>34</fpage>-<lpage>7</lpage>.<pub-id pub-id-type="pmid">15103456</pub-id></mixed-citation></ref><ref id="bibr25-1947603510376820"><label>25.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koshino</surname><given-names>T</given-names></name><name><surname>Murase</surname><given-names>T</given-names></name><name><surname>Saito</surname><given-names>T</given-names></name></person-group>
<article-title>Medial opening-wedge high tibial osteotomy with use of porous hydroxyapatite to treat medial compartment osteoarthritis of the knee</article-title>. <source>J Bone Joint Surg Am</source>. <year>2003</year>;<volume>85-A</volume>:<fpage>78</fpage>-<lpage>85</lpage>.<pub-id pub-id-type="pmid">12533576</pub-id></mixed-citation></ref><ref id="bibr26-1947603510376820"><label>26.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>van den Bekerom</surname><given-names>MP</given-names></name><name><surname>Patt</surname><given-names>TW</given-names></name><name><surname>Kleinhout</surname><given-names>MY</given-names></name><name><surname>van der Vis</surname><given-names>HM</given-names></name><name><surname>Albers</surname><given-names>GH</given-names></name></person-group>
<article-title>Early complications after high tibial osteotomy: a comparison of two techniques</article-title>. <source>J Knee Surg</source>. <year>2008</year>;<volume>21</volume>:<fpage>68</fpage>-<lpage>74</lpage>.<pub-id pub-id-type="pmid">18300676</pub-id></mixed-citation></ref><ref id="bibr27-1947603510376820"><label>27.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spahn</surname><given-names>G</given-names></name></person-group>
<article-title>Complications in high tibial (medial opening wedge) osteotomy</article-title>. <source>Arch Orthop Trauma Surg</source>. <year>2004</year>;<volume>124</volume>:<fpage>649</fpage>-<lpage>53</lpage>.<pub-id pub-id-type="pmid">14520581</pub-id></mixed-citation></ref><ref id="bibr28-1947603510376820"><label>28.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asik</surname><given-names>M</given-names></name><name><surname>Sen</surname><given-names>C</given-names></name><name><surname>Kilic</surname><given-names>B</given-names></name><name><surname>Goksan</surname><given-names>SB</given-names></name><name><surname>Ciftci</surname><given-names>F</given-names></name><name><surname>Taser</surname><given-names>OF</given-names></name></person-group>
<article-title>High tibial osteotomy with Puddu plate for the treatment of varus gonarthrosis</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source>. <year>2006</year>;<volume>14</volume>:<fpage>948</fpage>-<lpage>54</lpage>.<pub-id pub-id-type="pmid">16607564</pub-id></mixed-citation></ref><ref id="bibr29-1947603510376820"><label>29.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kitoh</surname><given-names>H</given-names></name><name><surname>Kitakoji</surname><given-names>T</given-names></name><name><surname>Tsuchiya</surname><given-names>H</given-names></name><name><surname>Katoh</surname><given-names>M</given-names></name><name><surname>Ishiguro</surname><given-names>N</given-names></name></person-group>
<article-title>Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones</article-title>. <source>Bone</source>. <year>2007</year>;<volume>40</volume>:<fpage>522</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">17070744</pub-id></mixed-citation></ref><ref id="bibr30-1947603510376820"><label>30.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roldan</surname><given-names>JC</given-names></name><name><surname>Jepsen</surname><given-names>S</given-names></name><name><surname>Miller</surname><given-names>J</given-names></name><name><surname>Freitag</surname><given-names>S</given-names></name><name><surname>Rueger</surname><given-names>DC</given-names></name><name><surname>Acil</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7</article-title>. <source>Bone</source>. <year>2004</year>;<volume>34</volume>:<fpage>80</fpage>-<lpage>90</lpage>.<pub-id pub-id-type="pmid">14751565</pub-id></mixed-citation></ref><ref id="bibr31-1947603510376820"><label>31.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mariconda</surname><given-names>M</given-names></name><name><surname>Cozzolino</surname><given-names>F</given-names></name><name><surname>Cozzolino</surname><given-names>A</given-names></name><name><surname>D&#x02019;Agostino</surname><given-names>E</given-names></name><name><surname>Bove</surname><given-names>A</given-names></name><name><surname>Milano</surname><given-names>C</given-names></name></person-group>
<article-title>Platelet gel supplementation in long bone nonunions treated by external fixation</article-title>. <source>J Orthop Trauma</source>. <year>2008</year>;<volume>22</volume>:<fpage>342</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="pmid">18448989</pub-id></mixed-citation></ref><ref id="bibr32-1947603510376820"><label>32.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Everts</surname><given-names>PA</given-names></name><name><surname>Brown Mahoney</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>JJ</given-names></name><name><surname>Schonberger</surname><given-names>JP</given-names></name><name><surname>Box</surname><given-names>HA</given-names></name><name><surname>van Zundert</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release</article-title>. <source>Growth Factors</source>. <year>2006</year>;<volume>24</volume>:<fpage>165</fpage>-<lpage>71</lpage>.<pub-id pub-id-type="pmid">17079200</pub-id></mixed-citation></ref><ref id="bibr33-1947603510376820"><label>33.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O&#x02019;Neill</surname><given-names>EM</given-names></name><name><surname>Zalewski</surname><given-names>WM</given-names></name><name><surname>Eaton</surname><given-names>LJ</given-names></name><name><surname>Popovsky</surname><given-names>MA</given-names></name><name><surname>Pivacek</surname><given-names>LE</given-names></name><name><surname>Ragno</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Autologous platelet-rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the preparation of platelet gel</article-title>. <source>Vox Sang</source>. <year>2001</year>;<volume>81</volume>:<fpage>172</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="pmid">11703860</pub-id></mixed-citation></ref><ref id="bibr34-1947603510376820"><label>34.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Marx</surname><given-names>RE</given-names></name></person-group>
<article-title>Commentary on: Bone regeneration in standardized bone defects with autografts or bone substitutes in combination with platelet concentrate: a histologic and histomorphometric study in the mandibles of minipigs</article-title>. <source>Int J Oral Maxillofac Implants</source>. <year>2006</year>;<volume>21</volume>:<fpage>190</fpage>-<lpage>1</lpage>.<pub-id pub-id-type="pmid">16634488</pub-id></mixed-citation></ref><ref id="bibr35-1947603510376820"><label>35.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kawasumi</surname><given-names>M</given-names></name><name><surname>Kitoh</surname><given-names>H</given-names></name><name><surname>Siwicka</surname><given-names>KA</given-names></name><name><surname>Ishiguro</surname><given-names>N</given-names></name></person-group>
<article-title>The effect of the platelet concentration in platelet-rich plasma gel on the regeneration of bone</article-title>. <source>J Bone Joint Surg Br</source>. <year>2008</year>;<volume>90</volume>:<fpage>966</fpage>-<lpage>72</lpage>.<pub-id pub-id-type="pmid">18591611</pub-id></mixed-citation></ref><ref id="bibr36-1947603510376820"><label>36.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Eppley</surname><given-names>BL</given-names></name><name><surname>Woodell</surname><given-names>JE</given-names></name><name><surname>Higgins</surname><given-names>J</given-names></name></person-group>
<article-title>Platelet quantification and growth factor analysis from platelet-rich plasma: implications for wound healing</article-title>. <source>Plast Reconstr Surg</source>. <year>2004</year>;<volume>114</volume>:<fpage>1502</fpage>-<lpage>8</lpage>.<pub-id pub-id-type="pmid">15509939</pub-id></mixed-citation></ref><ref id="bibr37-1947603510376820"><label>37.</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Ueda</surname><given-names>M</given-names></name><name><surname>Naiki</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Hata</surname><given-names>K</given-names></name><name><surname>Nagasaka</surname><given-names>T</given-names></name></person-group>
<article-title>Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration</article-title>. <source>Tissue Eng</source>. <year>2004</year>;<volume>10</volume>:<fpage>955</fpage>-<lpage>64</lpage>.<pub-id pub-id-type="pmid">15265313</pub-id></mixed-citation></ref></ref-list></back></article>